Doctor Oscar Rafael Escate Chavez

IIB Sant Pau-CIBERCV, Barcelona (Spain)

Follow

Contributor content

MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis

Presentation

MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis

ESC 365 is supported by

novartis

Explore sponsored resources